Daratumumab (anti-CD38) | CD markers | Read Reviews & Product Use Citations

Daratumumab (anti-CD38) is a recombinant monoclonal antibody to CD38. Daratumumab is an investigational anti-cancer drug which is indicated for the treatment of adult patients with multiple myeloma. MW =145.4 kDa.

Click to purchase the isotype control of Daratumumab (anti-CD38)

Selleck's Daratumumab (anti-CD38) has been cited by 1 publication

Purity & Quality Control

Batch: Purity: 99% Protein concentration: 5.72 mg/ml Endotoxin Level: ＜1EU/mg

99

Choose Selective CD markers Inhibitors

Biological Activity

Description	Daratumumab (anti-CD38) is a recombinant monoclonal antibody to CD38. Daratumumab is an investigational anti-cancer drug which is indicated for the treatment of adult patients with multiple myeloma. MW =145.4 kDa.

Product Details

CAS No.	945721-28-8
Isotype	Human IgG1
Source	Human
Formulation	PBS Buffer, PH 7.4
Storage (From the date of receipt)	Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field